Impact of Self-monitoring of Blood Pressure and Self-titration of Medication in the Control of Hypertension (ADAMPA)

NACompletedINTERVENTIONAL
Enrollment

366

Participants

Timeline

Start Date

July 21, 2017

Primary Completion Date

July 1, 2019

Study Completion Date

August 25, 2020

Conditions
HypertensionAdjustmentAdherence, Medication
Interventions
OTHER

Self-monitoring/Self-titration

"The intervention of the ADAMPA trial is not pharmacological but an intervention that modifies usual clinical practice. The intervention of self-monitoring and self-titration of the medication is composed of 3 elements:~1. Education of the patient: information and training on hypertension, its risks, management, the benefits of an adequate control and the generic measures for an optimal control.~2. Training for self-monitoring: Patients will be trained to perform the self-measurement of blood pressure correctly (and recording their values in the sheet enabled for this purpose)~3. Training for self-titration: patients will be instructed on the target BP numbers, individualized for each patient, on the mode of action against specific figures, including self-adjustment of drug treatment."

Trial Locations (1)

Unknown

Departamento de Salud Valencia Clínico Malvarrosa, Valencia

All Listed Sponsors
collaborator

Spanish Clinical Research Network - SCReN

NETWORK

collaborator

Carlos III Health Institute

OTHER_GOV

lead

Fundación para la Investigación del Hospital Clínico de Valencia

OTHER

NCT03242785 - Impact of Self-monitoring of Blood Pressure and Self-titration of Medication in the Control of Hypertension (ADAMPA) | Biotech Hunter | Biotech Hunter